A number of sociodemographic and psychosocial factors have been associated with non-adherence to Antiretroviral Therapy (ART). This study aimed to assess whether, by paying for medication, Bobby Goldsmith Foundation (BGF) improves the adherence levels of clients at risk of non-adherence due to these factors. Methods: BGF conducted face to face and phone interviews with 300 PLWH in NSW who were current clients assessed as more at risk of non-adherence due to their psychosocial and sociodemographic factors. The survey consisted of two sections. Firstly, participants were asked to provide demographic and lifestyle information. Participants were then asked a number of questions to investigate their adherence to ART over the past month, reasons for non-adherence and whether BGF’s assistance with the copayment of ART improved adherence levels.
Results: 88% of the respondents were male, 11% female and 1% transgender. 30% were born overseas and 4% were indigenous. 5% were homeless and 47% had a diagnosed mental illness. Participant’s self-reporting on adherence varied, with a number of participants reporting 100% adherence when they had ‘only’ missed taking their medication a few times during the month. Age, gender, ethnicity and AOD use were associated with adherence levels and participants ability to follow their doctor’s instructions. The most common reasons participants gave for missing their ARTs were forgetting, being too busy and changing their routine. Participants who were indigenous, were homeless, had frequent AOD use and / or had low literacy rates were most reliant on BGF’s copayment of ARTs to maintain adherence.
Conclusion: Rates of adherence amongst NSW’s most vulnerable PLWH are considerably lower than average adherence rates. BGF’s assistance with the copayment of ARTs is vital for maintaining some level of adherence amongst marginalised PLWH however organisations working with PLWH need to address the other barriers to adherence amongst these populations for treatment as prevention to be fully effective.
The case is of a 30 year-old HIV positive Zimbabwean woman (UK resident) who arrived in Australia in January 2011 on a one-year working visa. She was diagnosed with HIV in 2003 in the UK and commenced on Atripla® in 2005. She was first seen in Adelaide in May 2011, requesting a script for Atripla.®.
Background: Liquid based anal Papanicolaou smears, followed by High Resolution Anoscopy (HRA) guided biopsies are increasingly being advocated to identify areas of High Grade Anal Intraepithelial Neoplasia (HGAIN). We hypothesized that the ability to identify HGAIN would increase with experience of the anoscopist, and that comparison with contemporary Papanicolaou smears might yield insights into technical abilities.
Indigenous Australians experience a greater burden of sexually transmitted infections, however are less likely than the general population to access sexual health services. We examined the effectiveness of an Indigenous cultural appropriateness audit in assessing a sexual health clinic with low rates of Indigenous clients.
Despite the high proportion of young people annually accessing general practices, including Aboriginal Medical Services (AMS), testing for Chlamydia trachomatis remains relatively low in urban areas. A project officer was employed within the Institute of Urban Indigenous Health (IUIH) to serve a mentoring and facilitation role for the SE Queensland network of AMS and their sexual health workers, with a view to improving testing, management and follow-up of chlamydia and other STIs by community controlled medical services.
Monocytes are a heterogeneous cell population having specialised functions and differing phenotype. They are a link between innate immune system and adaptive immune system therefore, to identify if immune activation exists in HIV-1 individuals with controlled virema and recovered CD4 T cell counts, we assessed cell surface monocyte activation markers (MAM) within the monocyte subsets.
Involving consumers in healthcare decisions is important for high quality care. We previously tested a brief, consumer-led intervention consisting of three questions in a trial employing trained, standardized patients. The intervention enhanced discussion of evidence and increased patient involvement. We now report a research translation study which tested implementation with real patients at a reproductive and sexual health clinic.